Autoimmunity in myocarditis and dilated cardiomyopathy: Cardiac autoantibody frequency and clinical correlates in a patient series from Italy

Giornale Italiano di Cardiologia

Volumn 27, Issue 2, 1997, Pages 106-112

  Caforio, Alida L P ^a   Bauce, Barbara ^a   Boffa, Giovanni M ^a   De Cian, Francesca ^a   Angelini, Annalisa ^a   Melacini, Paola ^a   Razzolini, Renato ^a   Fasoli, Giuseppe ^a   Chioin, Raffaello ^a   Schiaffino, Stefano ^a   Thiene, Gaetano ^a   Dalla Volta, Sergio ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Autoimmunity; Myocardial disease

Indexed keywords

AUTOANTIBODY;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; ELECTROCARDIOGRAPHY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEART MUSCLE; HEMODYNAMICS; HUMAN; IMMUNOLOGY; INFANT; ITALY; MALE; MIDDLE AGED; MYOCARDITIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; ELECTROCARDIOGRAPHY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEMODYNAMIC PROCESSES; HUMANS; INFANT; ITALY; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM;

EID: 0031063259     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. DONIACH D, BOTTAZZO GF: Endocrine and other organ-oriented autoimmune disorders. In: DONIACH D, BOTTAZZO GF (eds): Clinical immunology and allergy, Vol 1. London, Bailliere, 1987.
2. MAISCH B, DEEG P, LIEBAU G, KOCHSIEK K: Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 1983; 52: 1072-1078.
3. SCHULTHEISS HP, BOLTE HD: Immunological analysis of autoantibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 1985; 17: 603-617.
4. LIMAS CJ, GOLDENBERG IF, LIMAS C: Autoantibodies against β-adrenoceptors in human dilated cardiomyopathy. Circ Res 1989; 64: 97-103.
5. 1 adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1990; 86: 1658-1663.
6. CAFORIO ALP, GRAZZINI M, MANN JM, ET AL: Identification of the α and β myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992; 85: 1734-1742.
7. CAFORIO ALP, BONIFACIO E, STEWART JT, ET AL: Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990; 15: 1527-1534.
8. BILINSKA ZT, CAFORIO ALP, GRZYBOWSKI J, ET AL: Organ-specific cardiac autoantibodies in dilated cardiomyopathy: frequency and clinical correlates in Polish patients. Eur Heart J 1995; 16: 1907-1911.
9. NEUMANN DA, BUREK CL, BAUGHMAN KL, ROSE NR, HERSKOWITZ A: Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol 1990; 16: 839-846.
10. SANDERSON JE, GOLDMAN JH, CAFORIO ALP, ET AL: Immune mechanisms in Chinese patients with idiopathic dilated cardiomyopathy (abstract). Heart Failure 1995; 2 (May, special issue): 765.
11. CAFORIO ALP, KEELING PJ, ZACHARA E, ET AL: Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 1994; 344: 773-777.
12. GOLDMAN JH, KEELING PJ, WARRAICH RS, ET AL: Evidence from family studies of autoimmunity to α-myosin in idiopathic dilated cardiomyopathy. Br Heart J 1995; 74: 598-603.
13. WOODRUFF J: Viral myocarditis - a review. Am J Pathol 1980; 101: 427-479.
14. KASPER EK, AGEMA WR, HUTCHINS GM, DECKERS JW, HOARE JM, BAUGHMAN KL: The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 1994; 23: 586-590.
15. CAFORIO ALP, MCKENNA WJ: Recognition and optimum management of myocarditis. Drugs 1996; 52: 515-525.
16. CAFORIO ALP: Role of autoimmunity in dilated cardiomyopathy. Br Heart J 1994; 72 (Suppl): 30-34.
17. WALLUKAT G, MORWINSKI M, KOWAL K, FORSTER A, BOEWER V, WOLLENBERGER A: Antibodies against the β-adrenergic receptor in human myocarditis and dilated cardiomyopathy: β-adrenergic agonism without desensitization. Eur Heart J 1991; 12 (Suppl D): 178-181.
18. LAUER B, PADBERG K, SCHULTHEISS HP, STRAUER BE: Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J Am Coll Cardiol 1994; 23: 146-153.
19. CAFORIO ALP, GOLDMAN JH, HAVEN AJ, BAIG KM, DALLA LIBERA L, MCKENNA WJ: Circulating cardiac autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. Eur Heart J 1997; 18, in press.
20. BRANDEBURG RO, CHAZOV E, CHERIAN G, ET AL: Report of the WHO/ISFC task force on definition and classification of the cardiomyopathies. Circulation 1981; 64: 437A-438A.
21. FUSTER V, GERSH BJ, GIULIANI ER, TAJIK AJ, BRANDEBURG RO, FRYE RL: The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47: 525-531.
22. SCHILLER NB: Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 1991; 84: 280-287.
23. MELACINI P, FANIN M, DANIELI GA, ET AL: Cardiac involvement in Becker Muscular Dystrophy. J Am Coll Cardiol, 1993; 22: 1927-1934.
24. GROSSMAN W, BAIM D: Cardiac catheterization, angiography and intervention. Philadelphia, Lea & Febiger, 1991.
25. ARETZ HT, BILLINGHAM ME, EDWARDS WE, ET AL: Myocarditis: a histopathologic definition and classification. Am J Cardiol Pathol 1985; 1: 1-10.
26. RICHARDSON P, MCKENNA WJ, BRISTOW M, ET AL: Report of the 1995 World Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-842.
27. BODMER WF: HLA-1987. In: BOOMER WF (ed): Immunobiology of HLA. New York, Springer-Verlag, 1989.
28. MICHELS W, MOLL PP, RODEHEFFER RJ, ET AL: Circulating heart antibodies in familial as compared with non-familial idiopathic cardiomyopathy. Mayo Clin Proc 1994: 69; 24-27.
29. CAFORIO ALP, GOLDMAN JH, BAIG MK, ET AL: Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart 1997; 77, in press.
30. MASON JW: Distinct forms of myocarditis. Circulation 1991; 83: 1110-1111.
31. ZHANG S, KODAMA M, HANAWA H, IZUMI T, SHIBATA A, MASANI F: Effects of cyclosporine, prednisolone and aspirin on rat autoimmune giant cell myocarditis. J Am Coll Cardiol 1993; 21: 1254-1260.
32. PARRILLO JE, CUNNION RE, EPSTEIN SE, ET AL: A prospective, randomized trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989; 321: 1061-1068.
33. MASON JW, O'CONNELL JB, HERSKOWITZ A, ET AL: A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333: 269-275.
34. LIEBERMAN EB, HUTCHINS GM, HERSKOWITZ A, ET AL: Clinicopathologic description of myocarditis. J Am Coll Cardiol 1991; 18: 1617-1626.
35. CHAN KY, IWAHARA M, BENSON LN, ET AL: Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial. J Am Coll Cardiol 1991; 17: 458-460.
36. O'CONNELL JH, DEC GW, GOLDENBERG IF, ET AL: Results of heart transplantation for active lymphocytic myocarditis. J Heart Transplant 1990, 9: 351-356.
37. KONG G, MADDEN B, SPYROU N, ET AL: Response of recurrent giant cell myocarditis in a transplanted heart to intensive immunosuppression. Eur Heart J 1991; 12: 554-557.